During the recent session, Exact Sciences Corp. (NASDAQ:EXAS)’s traded shares were 0.49 million, with the beta value of the company hitting 1.10. At the last check today, the stock’s price was $57.61, reflecting an intraday gain of 2.89% or $1.62. The 52-week high for the EXAS share is $87.11, that puts it down -51.21 from that peak though still a striking 29.49% gain since the share price plummeted to a 52-week low of $40.62. The company’s market capitalization is $10.64B, and the average intraday trading volume over the past 10 days was 4.15 million shares, and the average trade volume was 3.35 million shares over the past three months.
Exact Sciences Corp. (EXAS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.33. EXAS has a Sell rating from 0 analyst(s) out of 16 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 13 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.2.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exact Sciences Corp. (NASDAQ:EXAS) trade information
Exact Sciences Corp. (EXAS) registered a 2.89% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.89% in intraday trading to $57.61, hitting a weekly high. The stock’s 5-day price performance is -0.52%, and it has moved by 27.09% in 30 days. Based on these gigs, the overall price performance for the year is -31.82%. The short interest in Exact Sciences Corp. (NASDAQ:EXAS) is 13.98 million shares and it means that shorts have 4.36 day(s) to cover.
The consensus price target of analysts on Wall Street is $80, which implies an increase of 27.99% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $60 and $168 respectively. As a result, EXAS is trading at a discount of -191.62% off the target high and -4.15% off the low.
Exact Sciences Corp. (EXAS) estimates and forecasts
Statistics show that Exact Sciences Corp. has underperformed its competitors in share price, compared to the industry in which it operates. Exact Sciences Corp. (EXAS) shares have gone down -5.77% during the last six months, with a year-to-date growth rate less than the industry average at 11.50% against 16.40. In the rating firms’ projections, revenue will increase 13.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 718.73M as predicted by 22 analyst(s). Meanwhile, a consensus of 22 analyst(s) estimates revenue growth to 776.68M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 616.81M and 646.88M respectively. In this case, analysts expect current quarter sales to grow by 16.50% and then jump by 20.10% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 4.59%. While earnings are projected to return 15.63% in 2024.
EXAS Dividends
Exact Sciences Corp. is due to release its next quarterly earnings 2024-Oct-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Exact Sciences Corp. (NASDAQ:EXAS)’s Major holders
Exact Sciences Corp. insiders own 0.98% of total outstanding shares while institutional holders control 87.97%, with the float percentage being 88.84%. VANGUARD GROUP INC is the largest shareholder of the company, while 860.0 institutions own stock in it. As of 2024-03-31, the company held over 17.74 million shares (or 9.795% of all shares), a total value of $1.23 billion in shares.
The next largest institutional holding, with 13.03 million shares, is of CAPITAL WORLD INVESTORS’s that is approximately 7.143% of outstanding shares. At the market price on 2024-03-31, these shares were valued at $899.53 million.
